Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting375%
completed125%

Recent Activity

3 active trials
Showing 4 of 4
completednot_applicable

Rapid Eye Movement Restoration and Enhancement for Sleep-deprived Trauma-adaptation

NCT06547086
recruitingnot_applicable

Power Nap With TES-TI

NCT07090135
recruitingnot_applicable

Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 2

NCT06601699
recruitingnot_applicable

Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1

NCT06601686

Clinical Trials (4)

Showing 4 of 4 trials
NCT06547086Not Applicable

Rapid Eye Movement Restoration and Enhancement for Sleep-deprived Trauma-adaptation

Completed
NCT07090135Not Applicable

Power Nap With TES-TI

Recruiting
NCT06601699Not Applicable

Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 2

Recruiting
NCT06601686Not Applicable

Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4